Category: <span>Mitochondrial Protease Therapy</span>

Home / Mitochondrial Protease Therapy
Inhibition of Mitochondrial DNA Transcription as an Approach to Universal Cancer Therapy
Post

Inhibition of Mitochondrial DNA Transcription as an Approach to Universal Cancer Therapy

The key to a universal cancer therapy is to find a vulnerability that is (a) common to all cancers, something fundamental to cancer as a class, (b) nowhere near as prevalent in normal cells, and (c) can be cost-effectively exploited as a basis for treatment. Lengthening of telomeres is a good example, and an area in which at...

New drug inhibits the growth of cancer cells
Post

New drug inhibits the growth of cancer cells

MAX-PLANCK-GESELLSCHAFT IMAGE: CARTOON REPRESENTATION OF THE POLRMT-INHIBITOR COMPLEX. CREDIT: HAUKE S. HILLEN A newly developed compound starves cancer cells by attacking their “power plants” – the so-called mitochondria. The new compound prevents the genetic information within mitochondria from being read. Researchers from the Max Planck Institute for Biology of Ageing in Cologne, the Karolinska Institute...

Reducing proton leak restores function in aging heart cells
Post

Reducing proton leak restores function in aging heart cells

Blocking proton leaks in mitochondria via a transport protein can rejuvenate aging heart cells and helps reverse aging heart dysfunction. Scientists have revealed a mechanism that causes heart cells to age and identified a drug that can rejuvenate them, according to a study published in eLife.  The drug is now in clinical trials. The results provide...

Probe detects the destruction of defective mitochondria
Post

Probe detects the destruction of defective mitochondria

by RIKEN Figure 1: Colored transmission electron micrograph of a single mitochondrion in a human pancreas cell. RIKEN researchers have developed a fluorescent probe that can detect the programmed death of defective mitochondria in the lysosomes. Credit: K.R. PORTER/ SCIENCE PHOTO LIBRARY A versatile probe that can detect with pinpoint accuracy the programmed destruction of...

Scientists decipher key mechanism in hypoxia
Post

Scientists decipher key mechanism in hypoxia

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) The figure illustrates the role of the mitochondrial Ca2+/Na+ exchanger (NCLX) in the early adaptation to low oxygen concentrations (hypoxia) through the entry of sodium into the mitochondrial interior. This role is exemplified by hypoxic vasoconstriction of the pulmonary artery, which connects the heart to the...

New molecular tool precisely edits mitochondrial DNA
Post

New molecular tool precisely edits mitochondrial DNA

UW microbiologists discovered a bacterial toxin that, when engineered, is a key part of a gene editor that can make single-base changes in human mitochondria. The genome in mitochondria — the cell’s energy-producing organelles — is involved in disease and key biological functions, and the ability to precisely alter this DNA would allow scientists to...

OPTN-ATG9 interaction accelerates autophagic degradation of ubiquitin-labeled mitochondria
Post

OPTN-ATG9 interaction accelerates autophagic degradation of ubiquitin-labeled mitochondria

TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE DAMAGED MITOCHONDRIA ARE SELECTIVELY ELIMINATED VIA AUTOPHAGY CALLED MITOPHAGY. IN MAMMALIAN CELLS, UBIQUITIN CHAINS ON THE DAMAGED MITOCHONDRIA PLAY CRITICAL ROLES TO INDUCE MITOPHAGY. Researchers at TMIMS have revealed that PINK1 (a serine/threonine kinase) and Parkin (a ubiquitin ligating enzyme: E3) work together to ubiquitylate the outer membrane proteins...

Cyclosporin study may lead to novel ways of approaching mitochondrial dysfunction
Post

Cyclosporin study may lead to novel ways of approaching mitochondrial dysfunction

Cyclic peptide molecules of the fungal origin called cyclosporins were discovered in 1970’s, and cyclosporin A soon became an important drug due to its immunosuppressive activity. The details of the biochemical reactions involving cyclosporin were elucidated by the beginning of 1990s, but still some aspects of the behavior of this molecule raise questions. Investigation started...

Post

The brain’s powerhouses are damaged in Creutzfeldt-Jacob disease

Charlampos “Haris” Tzoulis with groundbreaking research on Creutzfeldt-Jacob disease. Credit: Ingvild Festervoll Melien A study performed by researchers from the University of Bergen, Norway, and the University of Vienna, Austria, shows damage of the mitochondria—the cell’s microscopic powerhouses—in the brains of people with Creutzfeldt-Jacob disease. The researchers found that the mitochondrial power generator (known as...